Carna Inc.

BOSTON, MA · Founded 2021 · CIK 0002055006 · Medtech · Private

AI-powered platform combining point-of-care testing devices with predictive analytics for cardio-kidney-metabolic syndrome detection and management

carna.health →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.4M
1 Form D · Feb 2025
20 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,400,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1127ZeoVation, Inc.—$780K
1128NOTA Laboratories, Inc.——
1129SPERRY MEDTECH INC.——
1130Carna Inc.—$3.4M
1131OLI Technologies, Inc.—$700K
1132Fresenius Medical Care Obetz, LLC—$2.7M
1133SynergyMed Devices Inc.—$141K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Boris BeratDirector · Executive Officer · Promoter
  • Thomas DolanExecutive Officer
  • Michelle LongmireDirector
  • Juan MarichalPromoter
  • Justin NguyenExecutive Officer
  • Jose PereyraDirector · Promoter
  • Faisal RushoExecutive Officer
  • Mary SallahExecutive Officer
  • Salvatore ViscomiDirector · Executive Officer · Promoter
  • David VogelPromoter

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.